Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique

Vaccine

Volumn 30, Issue 43, 2012, Pages 6180-6185

  Clifford, Holly D ^a,b   Hayden, Catherine M ^a   Khoo, Siew Kim ^a,b   Naniche, Denise ^c,d   Mandomando, Inacio M ^c,e   Zhang, Guicheng ^a,b   Richmond, Peter ^a,b   Le Souëf, Peter N ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Ministérioda Saúde   (Mozambique)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

Author keywords

Africa; Antibody; Innate immunity; Measles; Polymorphism; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; MEASLES VACCINE;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CD209 ANTIGEN GENE; CD46 GENE; CHILD; CONTROLLED STUDY; CYTOSOL; DNA POLYMORPHISM; DRUG TREATMENT FAILURE; GENE; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFANT; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MEASLES; MOZAMBIQUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RIG 1 GENE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SLAM GENE; TOLL LIKE RECEPTOR 3 GENE; TOLL LIKE RECEPTOR 7 GENE; TOLL LIKE RECEPTOR 8 GENE; TREATMENT RESPONSE; VACCINATION;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, CD46; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MEASLES; MEASLES VACCINE; MOZAMBIQUE; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 8; TREATMENT FAILURE;

EID: 84865718104     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.063     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention (CDC). Global measles mortality, 2000-2008. Wkly Epidemiol Rec 2009;58(47):1321-6.
2. Jani J.V., Jani I.V., Araújo C., Sahay S., Barreto J., Bjune G. Assessment of routine surveillance data as a tool to investigate measles outbreaks in Mozambique. BMC Infect Dis 2006, 6:29.
3. Mandomando I.M., Naniche D., Pasetti M.F., Valles X., Cuberos L., Nhacolo A., et al. Measles-specific neutralizing antibodies in rural Mozambique: seroprevalence and presence in breast milk. Am J Trop Med Hyg 2008, 79(5):787-792.
4. Brunell P.A., Weigle K., Murphy M.D., Shehab Z., Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 1983, 250:1409-1412.
5. Akande T.M. A review of measles vaccine failure in developing countries. Nigerian Med Practitioner 2007, 52(5-6):112-116.
6. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993, 67:6025-6032.
7. Erlenhofer C., Duprex W.P., Rima B.K., Ter Meulen V., Schneider-Schaulies J. Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol 2002, 83:1431-1436.
8. de Witte L., Abt M., Schneider-Schaulies S., van Kooyk Y., Geijtenbeek T.B. Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 2006, 80(7):3477-3486.
9. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17(1):1-14.
10. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001, 413:732-738.
11. Lee J., Chuang T.H., Redecke V., She L., Pitha P.M., Carson D.A., et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 2003, 100(11):6646-6651.
12. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
13. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303(5663):1529-1531.
14. Tanabe M., Kurita-Taniguchi M., Takeuchi K., Takeda M., Ayata M., Ogura H., Matsumoto M., Seya T. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem Biophys Res Commun 2003, 311:39-48.
15. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5(7):730-737.
16. Clifford H.D., Richmond P., Khoo S.K., Zhang G., Yerkovich S.T., Le Souëf P.N., et al. SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine. Vaccine 2011, 29(33):5407-5413.
17. Clifford H.D., Yerkovich S.T., Khoo S.K., Zhang G., Upham J., Le Souëf P.N., et al. Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine. Immunogenetics 2012, 64(3):219-228.
18. Clifford H.D., Hayden C.M., Khoo S.K., Zhang G., Le Souëf P.N., Richmond P. CD46 measles receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive Australian children. Clin Vaccine Immunol 2012, 19(5):704-710.
19. Clifford H.D., Yerkovich S.T., Khoo S.K., Zhang G., Upham J., Le Souëf P.N., et al. TLR3 and RIG-I gene variants: associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants. Hum Immunol 2012, 73(6):677-685.
20. Mandomando I., Naniche D., Pasetti M.F., Cuberos L., Sanz S., Vallès X., et al. Assessment of the epidemiology and burden of measles in Southern Mozambique. Am J Trop Med Hyg 2011, 85(1):146-151.
21. Alonso P.L., Saute F., Aponte J.J., Gómez-Olivé F.X., Nhacolo A., Thompson R., et al. Manhiça De mographic Surveillance System (DSS) Mozambique. Population and health in developing countries INDEPTH, Vol. 1 2002, International Development Research Centre (IDRC), Ottawa, pp. 189-195.
22. Tapia M.D., Sow S.O., Medina-Moreno S., Lim Y., Pasetti M.F., Kotloff K., et al. A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali. Am J Trop Med Hyg 2005, 3:26-31.
23. Hoffmann S.C., Stanley E.M., Cox E.D., DiMercurio B.S., Koziol D.E., Harlan D.M., et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002, 2:560-567.
24. Dhiman N., Poland G.A., Cunningham J.M., Jacobson R.M., Ovsyannikova I.G., Vierkant R.A., et al. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol 2007, 120:666-672.
25. Dhiman N., Ovsyannikova I.G., Vierkant R.A., Ryan J.E., Pankratz V.S., Jacobson R.M., et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008, 26(14):1731-1736.
26. Martin M.P., Lederman M.M., Hutcheson H.B., Goedert J.J., Nelson G.W., van Kooyk Y., et al. Association of DC-SIGN promoter polymorphism with increased risk for parenteral: but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 2004, 78(24):14053-14056.
27. Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A., Lowhnoo T., Kajaste-Rudnitski A., et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005, 37(5):507-513.
28. Ranjith-Kumar C.T., Miller W., Sun J., Xiong J., Santos J., Yarbrough I., et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem 2007, 282(24):17696-17705.
29. Oh D.Y., Taube S., Hamouda O., Kücherer C., Poggensee G., Jessen H., et al. A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis 2008, 198(5):701-709.
30. Oh D.Y., Baumann K., Hamouda O., Eckert J.K., Neumann K., Kücherer C., et al. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 2009, 23(3):297-307.
31. Davila S., Hibberd M.L., Hari Dass R., Wong H.E., Sahiratmadja E., Bonnard C., et al. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet 2008, 4(10):e1000218.
32. Black J.B., Durigon E., Kite-Powell K., de Souza L., Curli S.P., Afonso A.M., et al. Seroconversion to human herpesvirus 6 and human herpesvirus 7 among Brazilian children with clinical diagnoses of measles or rubella. Clin Infect Dis 1996, 23(5):1156-1158.
33. Ministério da Saúde, Maputo, Mozambique. [Available at: ]. http://www.misau.gov.mz/pt/epidemias_endemias/vigilancia_epidemiologic.
34. Ovsyannikova I.G., Pankratz V.S., Vierkant R.A., Jacobson R.M., Poland G.A. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis 2006, 193:655-663.
35. Dhiman N., Ovsyannikova I.G., Cunningham J.M., Vierkant R.A., Kennedy R.B., Pankratz V.S., et al. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007, 195:21-29.
36. Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. Associations between cytokine/cytokine receptor SNPs and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 2008, 72(3):211-220.
37. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 1998, 316:1236-1238.
38. Poland G.A., Ovsyannikova I.G., Jacobson R.M. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008, 8(11):1659-1667.